Primary Malignant Fibrous Histiocytoma: A Rare Case | Zendy

Anastasios Katsourakis | Zendy; George Noussios | Zendy; Iosif Hadjis | Zendy; Neofitos Evangelou | Zendy; Efthimios Chatzitheoklitos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Primary Malignant Fibrous Histiocytoma: A Rare Case

Author(s) -

Anastasios Katsourakis,

George Noussios,

Iosif Hadjis,

Neofitos Evangelou,

Efthimios Chatzitheoklitos

Publication year - 2011

Publication title -

case reports in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 20

eISSN - 1687-9627

pISSN - 1687-9635

DOI - 10.1155/2011/134801

Subject(s) - medicine , gemcitabine , rare disease , natural history , adjuvant chemotherapy , sarcoma , jejunum , myalgia , trunk , chemotherapy , neoplasm , surgery , disease , pathology , cancer , ecology , breast cancer , biology

Malignant fibrous histiocytoma (MFH) of the small intestine is an extremely rare condition. It occurs most commonly in the extremities and the trunk. We report a case of a 67-year-old woman who admitted with fever, myalgia, and altered status. After thorough investigation, a tumor of the jejunum was found. The patient underwent complete surgical removal of the tumor. A diagnosis of MFN (undifferentiated high-grade pleomorphic sarcoma) was made. The patient received adjuvant chemotherapy with Gemcitabine. Two years after the operation, the patient died due to recurrence of the disease. MFH of the small intestine is an extremely rare neoplasm with an aggressive biological behaviour. In this paper, pathogenesis, natural history, and treatment are reviewed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research